According to the World Health Organization (WHO), cancer is the second leading cause of death, claiming ~10 million lives each year. Despite significant medical and technological advancements in this field, the global cancer burden is on the rise. Life sciences companies acknowledge this threat and are actively developing potential cancer treatments. Clinical trials for oncology drugs are on the rise. Although, as the drugs move through different phases of approvals, the likelihood of success is severely low.
On the other side of such drugs’ life cycle, market and data complexities make the commercialization process cumbersome. The situation invites the need for robust data and analytics techniques for informed decision-making. To succeed in this environment, companies need to leverage an appropriate mix of products and services to commercialize successful oncology drugs, helping cancer patients get closer to healthier lives.
Check out the infographic below to learn more about oncology:
